Testing Robustness: Immunosuppressant Drugs in Blood with a TSQ Quantis MS for Clinical Research

2 Mar 2018

Mass spectrometry is a popular choice of technology in clinical research for the quantitation of immunosuppressant drugs in whole blood samples. A sensitive and robust instrument is required for reliable quantitation workflows. In this study, the robustness of the TSQ Quantis triple quadrupole mass spectrometer for analysis of immunosuppressant drugs in whole blood samples in demonstrated.

Links

Tags